About TARGET PharmaSolutions
TARGET PharmaSolutions is a company based in Chapel Hill (United States) founded in 2015 by Meg Boothpowell and Michael Fried was acquired by Norwest Venture Partners in June 2016.. TARGET PharmaSolutions has raised $2 million across 1 funding round from investors including Novartis, Boehringer Ingelheim and Allergan.
- Headquarter Chapel Hill, United States
- Founders Meg Boothpowell, Michael Fried
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$2 M (USD)
in 1 rounds
-
Latest Funding Round
$2 M (USD), Series A
Jan 13, 2016
-
Investors
Novartis
& 6 more
-
Employee Count
Employee Count
-
Acquired by
Norwest Venture Partners
(Jun 01, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of TARGET PharmaSolutions
TARGET PharmaSolutions has successfully raised a total of $2M through 1 strategic funding round. The most recent funding activity was a Series A round of $2 million completed in January 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $2.0M
-
First Round
First Round
(13 Jan 2016)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2016 | Amount | Series A - TARGET PharmaSolutions | Valuation | Rex Health Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in TARGET PharmaSolutions
TARGET PharmaSolutions has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Novartis, Boehringer Ingelheim and Allergan. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Early-stage ventures in the Southeast are supported by VentureSouth.
|
Founded Year | Domain | Location | |
|
Venture capital and growth equity firm providing investments and resources to entrepreneurs in various sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by TARGET PharmaSolutions
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - TARGET PharmaSolutions
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Target Pharmasolutions Comparisons
Competitors of TARGET PharmaSolutions
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about TARGET PharmaSolutions
When was TARGET PharmaSolutions founded?
TARGET PharmaSolutions was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Where is TARGET PharmaSolutions located?
TARGET PharmaSolutions is headquartered in Chapel Hill, United States. It is registered at Chapel Hill, North Carolina, United States.
Who is the current CEO of TARGET PharmaSolutions?
Michael Mckelvey is the current CEO of TARGET PharmaSolutions.
Is TARGET PharmaSolutions a funded company?
TARGET PharmaSolutions is a funded company, having raised a total of $2M across 1 funding round to date. The company's 1st funding round was a Series A of $2M, raised on Jan 13, 2016.
What does TARGET PharmaSolutions do?
TARGET PharmaSolutions was established in 2015 in Chapel Hill, United States. Clinical data management and consulting services are delivered to support pharmaceutical operations. Focus is placed on data handling, analysis, and advisory expertise within the healthcare sector. The company is led by co-founders Meg Boothpowell and Michael Fried, alongside CEO Michael Mckelvey. Activities are centered in the U.S., addressing needs in clinical research and compliance.
Who are TARGET PharmaSolutions's investors?
TARGET PharmaSolutions has 7 investors. Key investors include Novartis, Boehringer Ingelheim, Allergan, Norwest Venture Partners, and Rex Health Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.